PMC:7402624 / 58569-58738
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T498 | 154-158 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1884 | 45-53 | Species | denotes | patients | Tax:9606 |
| 1885 | 119-127 | Species | denotes | patients | Tax:9606 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T903 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T904 | 152-158 | http://purl.obolibrary.org/obo/CL_0000236 | denotes | B cell |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T341 | 0-169 | Sentence | denotes | A key question will be how to identify these patients for selected immune regulatory treatment while avoiding treating patients with already weak T and B cell responses. |